Ingevity Corp (NGVT) Director Acquires $87,570.00 in Stock

Ingevity Corp (NASDAQ:NGVT) Director Jean S. Blackwell acquired 1,500 shares of the firm’s stock in a transaction that occurred on Monday, May 15th. The shares were purchased at an average cost of $58.38 per share, with a total value of $87,570.00. Following the completion of the acquisition, the director now owns 4,711 shares in the company, valued at approximately $275,028.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Ingevity Corp (NASDAQ:NGVT) last posted its quarterly earnings results on Wednesday, May 3rd. The company reported $0.49 EPS for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.02. The company had revenue of $218.50 million during the quarter, compared to analyst estimates of $206.90 million.

ILLEGAL ACTIVITY WARNING: “Ingevity Corp (NGVT) Director Acquires $87,570.00 in Stock” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.tickerreport.com/banking-finance/2568246/ingevity-corp-ngvt-director-acquires-87570-00-in-stock.html.

Several analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of Ingevity Corp from a “hold” rating to a “sell” rating in a report on Wednesday, April 26th. Jefferies Group LLC upped their price objective on shares of Ingevity Corp from $64.00 to $68.00 and gave the stock a “buy” rating in a report on Wednesday, April 19th. Finally, Aegis reaffirmed a “buy” rating and set a $67.00 price objective (up from $60.00) on shares of Ingevity Corp in a report on Thursday, April 6th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $57.17.

A number of hedge funds and other institutional investors have recently bought and sold shares of NGVT. Panagora Asset Management Inc. increased its position in Ingevity Corp by 40.1% in the third quarter. Panagora Asset Management Inc. now owns 322,209 shares of the company’s stock worth $14,854,000 after buying an additional 92,213 shares during the period. Russell Investments Group Ltd. bought a new position in Ingevity Corp during the fourth quarter worth approximately $1,605,000. Rhumbline Advisers increased its position in Ingevity Corp by 6.1% in the third quarter. Rhumbline Advisers now owns 61,568 shares of the company’s stock worth $2,838,000 after buying an additional 3,518 shares during the period. BlackRock Institutional Trust Company N.A. increased its position in Ingevity Corp by 6.1% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 1,054,831 shares of the company’s stock worth $48,628,000 after buying an additional 60,285 shares during the period. Finally, Comerica Bank increased its position in Ingevity Corp by 25.1% in the fourth quarter. Comerica Bank now owns 67,849 shares of the company’s stock worth $3,596,000 after buying an additional 13,634 shares during the period.

About Ingevity Corp

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.

5 Day Chart for NASDAQ:NGVT

Receive News & Ratings for Ingevity Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Blackberry Returns as Stock Surges Following WannaCry
Blackberry Returns as Stock Surges Following WannaCry
Flight Attendants Accuse Frontier Airlines of Not Allowing Breast Feeding
Flight Attendants Accuse Frontier Airlines of Not Allowing Breast Feeding
General Motors’ Maven Launches in New York City
General Motors’ Maven Launches in New York City


Leave a Reply

© 2006-2017 Ticker Report. Google+.